Nasdaq · Common stock
Retension Pharmaceuticals (RTSN)
$14.24 −$1.01 (−6.62%)
- Day’s range
- $14.24–$15.82
- Volume
- 47,165
RTSN price history
RTSN closed at $14.24 on Oct. 26, 2026. Over the past year, its daily close ranged from $10.53 on Oct. 9, 2026 to $16.33 on Oct. 19, 2026.
Data table: RTSN daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $14.24 |
| Oct. 23, 2026 | $15.25 |
| Oct. 22, 2026 | $15.50 |
| Oct. 21, 2026 | $15.00 |
| Oct. 20, 2026 | $16.18 |
| Oct. 19, 2026 | $16.33 |
| Oct. 16, 2026 | $14.07 |
| Oct. 15, 2026 | $12.21 |
| Oct. 14, 2026 | $11.64 |
| Oct. 13, 2026 | $11.63 |
| Oct. 12, 2026 | $11.32 |
| Oct. 9, 2026 | $10.53 |
Key figures
- Average daily volume
- 186,896Past 3 months
- Market value
- $118.6M
- Dividend yield
- —
What Wall Street says about RTSN
No Wall Street firm has published a rating or price-target change on RTSN in the past 90 days.
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Retension Pharmaceuticals, Inc. Common Stock
Retension Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product candidate, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 (PDE-5) inhibitor designed to reduce blood pressure.
- Listed
- Oct. 9, 2026
In WallStreetDigest editions
No WallStreetDigest article about RTSN is on the site yet.